HUMA PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

HUMA ▲ +27.36% at T+20d

NEUTRAL call ✓ call won +27.36% · α vs SPY +27.34% · entry $1.06 → $1.35

Next anchor: T+60d in 7w

Last close $1.05 (close Jun 12) · -0.47% from $1.06 entry

Entry anchored
May 7, 03:59 PM ET
via Databento tick

T+1d

-5.66%

call -5.66% · α -5.89%

$1.00

settled 5w ago

T+5d

-5.66%

call -5.66% · α -7.12%

$1.00

settled 4w ago

T+20d

+27.36%

call +27.36% · α +27.34%

$1.35

settled 7d ago

T+60d

—

call — · α —

—

in 7w

Price Chart

Loading chart...

Executive Summary

Humacyte announced it will release Q1 2026 financial results on May 13, 2026, with no preliminary financial data or guidance provided in this press release. The filing is a routine earnings date announcement with no material financial information, making it a non-event for traders.

Actionable Insight

This is a routine earnings date announcement with no financial content. The market-moving event will be the Q1 2026 earnings release on May 13, 2026. Monitor for Symvess commercial launch metrics and ATEV pipeline updates in the upcoming report.

Key Facts

Q1 2026 earnings release scheduled for May 13, 2026, before market open
No preliminary financial results or guidance provided in this press release
Conference call scheduled for 8:00 a.m. ET on May 13, 2026
Symvess (ATEV) received FDA approval for vascular trauma indication in December 2024

Financial Impact

No financial data disclosed in this filing

Risk Factors

No financial data or guidance provided in this filing
Commercial adoption of Symvess remains unquantified
Company has history of significant EPS misses (Jun 2025: -60% miss vs consensus)

Market Snapshot

Exchange

Nasdaq

Sector

Biological Products, (No Diagnostic Substances)

Analyst Consensus

85% bullish (13 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3291035

11 reports for HUMA

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for HUMA — sortable, filterable
	Type				Now
Jun 12, 2026 2d ago	Institutional Cluster BULLISH ★ 5/10	$1.07 awaiting T+5	awaiting T+5	—	$1.05 (−0.94%)
Jun 11, 2026 3d ago	8-K BEARISH ★ 6/10	$1.07 awaiting T+5	awaiting T+5	—	$1.05 (+1.40%)
Jun 11, 2026 4d ago	Press Release BEARISH ★ 6/10	$1.16 awaiting T+5	awaiting T+5	—	$1.05 (+9.05%)
Jun 11, 2026 4d ago	Press Release BEARISH ★ 5/10	$1.16 awaiting T+5	awaiting T+5	—	$1.05 (+9.05%)
Jun 10, 2026 4d ago	Press Release BULLISH ★ 7/10	$1.35 awaiting T+5	awaiting T+5	—	$1.05 (−21.85%)
May 20, 2026 25d ago	Insider Cluster NEUTRAL ★ 3/10	$1.02 $1.28	▲ +25.49%	▲ +23.89%	$1.05 (+3.43%)
May 13, 2026 4w ago	Press Release MIXED ★ 6/10	$1.13 $0.8250	▼ −26.99%	▼ −25.83%	$1.05 (−6.64%)
May 8, 2026 5w ago	Press Release NEUTRAL ★ 2/10	$1.06 $1.00	▼ −5.66%	▼ −7.12%	$1.05 (−0.47%)
Apr 21, 2026 7w ago	Press Release BULLISH ★ 7/10	$0.6590 $0.8480	▲ +28.68%	▲ +27.60%	$1.05 (+60.09%)
Mar 23, 2026 11w ago	Press Release NEUTRAL ★ 3/10	$0.8500 $0.5750	▼ −32.35%	▼ −28.79%	$1.05 (+24.12%)

US Market Status

Market Closed — Opens in 4h 43m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access